Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism
Status:
Completed
Trial end date:
2017-09-09
Target enrollment:
Participant gender:
Summary
[18F]GP1 targets platelet GPIIb/IIIa receptor in thrombus. [18F]GP1 PET/CT imaging will
noninvasively assess thrombus in whole body with good sensitivity with information of
thrombus. Safety, pharmacokinetics, biodistribution, internal radiation dosimetry and
diagnostic performance of [18F]GP1 will be assessed in all subjects.